Brenda Destro

Author Archive

  • Dec 16, 2025
    When President Trump returned to the White House, many expected his Food and Drug Administration (FDA) to once again reflect the bold vision of his first term that encouraged faster...
  • Aug 8, 2025
    The recent $7.4 billion opioid settlement signed onto by all 50 States and U.S. territories with Purdue Pharma marks another milestone in the national effort to combat the...
  • May 26, 2025
    As drug companies face the possibility of increasing costs due to tariffs, there is little doubt that the impact on healthcare will be significant. According to an Ernst & Young...